15 employees
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
2020
$71M
from 2 investors over 2 rounds
BlossomHill Therapeutics, Inc. raised $71M on March 3, 2021
Investors: Vivo Capital and OrbiMed Advisors